Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) After A Viremic Event: A Pooled Analysis of Studies in People with HIV

Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) After A Viremic Event: A Pooled Analysis of Studies in People with HIV

Abstract Introduction Transient viremia can occur in people with human immunodeficiency virus (HIV), often referred to as people with HIV (PWH), and is sometimes related to poor adherence to antiretroviral therapy (ART). Guidelines recommend achieving virologic resuppression with existing ART regime...

Full description

Saved in:
Bibliographic Details
Main Authors: Anton Pozniak, Chloe Orkin, Yazdan Yazdanpanah, Axel Baumgarten, Karam Mounzer, Michelle L. D’Antoni, Hailin Huang, Hui Liu, Kristen Andreatta, Laurie A. VanderVeen, Christian Callebaut, Jason T. Hindman, José R. Arribas
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-04-01
Series:Infectious Diseases and Therapy
Subjects:
Adherence
Antiretroviral therapy
Bictegravir/emtricitabine/tenofovir alafenamide
Genotype analysis
Human immunodeficiency virus
Virologic suppression
Online Access:https://doi.org/10.1007/s40121-025-01153-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40121-025-01153-y

Similar Items